Perrigo (NYSE:PRGO) Posts Mixed Q3 2025 Results with EPS Beat and Revenue Miss

Last update: Nov 5, 2025

Perrigo Company PLC (NYSE:PRGO) reported financial results for the third quarter of 2025 that presented a mixed picture for investors. The company's performance relative to analyst expectations and its strategic announcements have contributed to notable price movements in its stock.

Earnings and Revenue Performance

Perrigo's Q3 2025 results revealed a significant divergence between its top-line revenue and bottom-line earnings per share when measured against Wall Street forecasts.

Revenue: The company reported revenue of $1.04 billion for the quarter. This figure fell short of the analyst consensus estimate of $1.12 billion.
Earnings Per Share (EPS): On a non-GAAP basis, Perrigo reported EPS of $0.80. This surpassed the analyst estimate of $0.77 per share.

The discrepancy highlights a quarter where the company managed to achieve higher-than-expected profitability despite generating less revenue than anticipated. This suggests effective cost control or favorable product mix, even as overall sales faced headwinds.

Market Reaction

The market's immediate response to the earnings release was negative. In pre-market trading, PRGO shares declined by approximately 1.34%. This sell-off indicates that investors may be focusing more heavily on the revenue miss than the earnings beat. The negative sentiment is further reflected in the stock's recent performance, which shows declines over the past week, two weeks, and month, suggesting a broader period of pressure leading up to the earnings announcement.

Strategic Review and Market Share

A key takeaway from the company's recent communications is the announcement of a strategic review of its infant formula business. This move signals that management is actively evaluating its portfolio to enhance shareholder value, potentially through a divestiture. This review could unlock value but also introduces an element of uncertainty regarding the future composition of the company's revenue streams.

Despite what the company described as "soft market consumption trends," Perrigo reported gaining market share in several key areas. According to the press release, the company achieved dollar, unit, and volume share gains in five out of seven Over-The-Counter store brand categories. It also secured dollar share gains for its key brands, demonstrating competitive strength in its core consumer self-care segments even in a challenging retail environment.

Looking Ahead

Analyst estimates for Perrigo's future performance provide a benchmark for the company's upcoming quarters. For the fourth quarter of 2025, the consensus estimates are for sales of $1.20 billion and revenue of $1.06 billion. For the full 2025 year, analysts are projecting sales of $4.47 billion and revenue of $3.05 billion. The company's ability to meet or exceed these future estimates, particularly on the top line, will be critical in shifting investor sentiment.

For a detailed breakdown of historical earnings and future analyst estimates for Perrigo, you can review the data here.

Disclaimer: This article is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions.